Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 EUR | -0.60% | -2.94% | +96.43% |
Sales 2024 * | 123M 133M | Sales 2025 * | 325M 352M | Capitalization | 2.57B 2.78B |
---|---|---|---|---|---|
Net income 2024 * | -430M -465M | Net income 2025 * | -116M -125M | EV / Sales 2024 * | 21.7 x |
Net Debt 2024 * | 89.28M 96.53M | Net cash position 2025 * | 94.69M 102M | EV / Sales 2025 * | 7.61 x |
P/E ratio 2024 * |
-6.04
x | P/E ratio 2025 * |
-32.7
x | Employees | 464 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.13% |
Latest transcript on MorphoSys AG
1 day | -0.60% | ||
1 week | -2.94% | ||
Current month | +4.43% | ||
1 month | +0.61% | ||
6 months | +320.92% | ||
Current year | +96.43% |
Managers | Title | Age | Since |
---|---|---|---|
Jean-Paul Kress
CEO | Chief Executive Officer | 59 | 19-08-31 |
Lucinda Crabtree
DFI | Director of Finance/CFO | 45 | 23-08-06 |
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brosnan
BRD | Director/Board Member | 69 | 18-05-16 |
Director/Board Member | 67 | 18-05-16 | |
Marc Cluzel
CHM | Chairman | 69 | 12-05-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 16.5 | -0.60% | 0 |
24-05-22 | 16.6 | 0.00% | 0 |
24-05-21 | 16.6 | -2.35% | 0 |
24-05-20 | 17 | -1.73% | 0 |
24-05-17 | 17.3 | +1.76% | 0 |
Delayed Quote Deutsche Boerse AG, May 23, 2024 at 03:05 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.43% | 62.59B | |
-1.70% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.08% | 26.21B | |
-21.78% | 19.09B | |
+4.48% | 13.08B | |
+25.62% | 12.26B | |
+28.20% | 12.05B |
- Stock Market
- Equities
- MOR Stock
- MOR2 Stock